Texas Rheumatology Research Institute, LLC

Plano, Texas 75024

2 studies enrolling now · 3 studies all time

What they study most

Lupus Erythematosus, Systemic, Lupus Nephritis, Sjogrens Syndrome

Studies at this site

• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis — Recruiting now
• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus — Recruiting now
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling